Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
BMC Neurology|March 18, 2023
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathyAaron Yarlas, Andrew Lovley, Duncan Brown, et al.Journal of Patient-Reported Outcomes|June 19, 2026
Psychometric validation of the Angioedema Quality of Life Questionnaire (AE-QoL) for hereditary angioedemaAlexandra J Feld, Martha Bayliss, Jakob B Bjorner, et al.Patient Related Outcome Measures|February 21, 2024
Cross-Sectional Quantitative Evaluation of a Novel Patient-Reported Outcome Measure in Familial Chylomicronemia SyndromeT Michelle Brown, Montserrat Vera-Llonch, Chisom Kanu, et al.Journal of Patient-Reported Outcomes|December 15, 2018
Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature reviewAaron Yarlas, Stephen M Maher, Martha S Bayliss, et al.Journal of Patient-Centered Research and Reviews|May 8, 2020
The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-AnalysisAaron Yarlas, Stephen Maher, Martha Bayliss, et al.Expert Opinion on Pharmacotherapy|February 5, 2013
Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back painKate Miller, Aaron Yarlas, Warren Wen, et al.BMC Neurology|February 13, 2021
Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysisXiaochen Lin, Aaron Yarlas, Montserrat Vera-Llonch, et al.The Patient|January 21, 2026
Patient Preferences for Long-Term Prophylactic Treatment in Hereditary Angioedema: A Discrete-Choice ExperimentKathleen F Villa, Carol Mansfield, Aaron Yarlas, et al.Neuropsychiatric Disease and Treatment|November 23, 2018
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorderRaymond W Lam, François-Xavier Lamy, Natalya Danchenko, et al.Rheumatology and Therapy|October 13, 2022
Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric AnalysesKimberly Raymond, Stephen Maher, Cory D Saucier, et al.Pageof 5